Saga picks up human genetics research segment and therapeutic pipeline, while Beryllium takes over two other divisions. deCODE genetics has voluntarily filed for Chapter 11 bankruptcy protection. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results